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Formulation and evaluation of galantamine gel as drug reservoir in transdermal 
patch delivery system 
ABSTRACT 
Galantamine hydrobromide is formulated in tablets and capsules prescribed through 
oral delivery for the treatment of Alzheimer’s disease. However, oral delivery of drugs 
can cause severe side effects such as nausea, vomiting, and gastrointestinal disturbance. 
Transdermal delivery of galantamine hydrobromide could avoid these unwanted side 
effects. In this work, galantamine hydrobromide was formulated in gel drug reservoir 
which was then fabricated in the transdermal patch. The in vitro drug release studies 
revealed that the drug release from the donor chamber to receptor chamber of Franz 
diffusion cell was affected by the amount of polymer, amount of neutralizer, amount of 
drug, types of permeation enhancer, and amount of permeation enhancer. Visual 
observations of the gels showed that all formulated gels are translucent, homogeneous, 
smooth, and stable. These gels have pH in the suitable range for skin. The gel also 
showed high drug content uniformity. Hence, this formulation can be further used in 
the preparation of transdermal patch drug delivery system. 
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